查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1867596

生物可吸收支架：全球市场占有率和排名、总收入和需求预测（2025-2031年）

Bioabsorbable Stents - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 97 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024年全球生物可吸收支架市场规模估计为7.53亿美元，预计到2031年将达到17.59亿美元，2025年至2031年的复合年增长率为13.2%。

本报告对近期生物可吸收支架的关税调整和国际战略反制措施进行了全面评估，包括跨境产业布局、资本配置模式、区域经济相互依存以及供应链重组。

生物可吸收支架是一种高阶植入式医疗设备，用于治疗心血管或週边动脉狭窄。这些支架旨在关键的癒合阶段提供机械支撑，然后逐渐降解并在体内消失。它们通常由聚左旋乳酸血栓症（PLLA）、镁合金或锌合金等可生物降解材料製成，从而避免了与永久性金属植入相关的併发症，例如延迟血栓形成、血管再阻塞以及对未来影像检查和介入治疗的干扰。作为介入治疗领域的变革性创新，生物可吸收支架代表着从「永久性支架」到「临时性癒合支撑」的转变，具有重要的临床价值，尤其适用于年轻患者和需要多次介入治疗的患者。它们目前正引领结构性心血管治疗器械的下一个发展阶段。 2024年，全球生物可吸收支架的产量约为37.6万个，全球平均市场价格约为每个2,000美元。

随着心血管疾病在全球日益普遍，微创介入治疗正逐渐成为临床标准。作为新一代高性能植入装置，生物可吸收支架正受到医疗系统和监管机构的广泛关注。多个国家已将这些产品纳入加速核准程序和创新试验计画，以加速其商业化进程。主要医疗设备製造商也增加对结构性心臟疾病治疗产品线的投入，显着拓展生物可吸收支架的临床应用范围，使其涵盖週边血管、神经血管和儿科等领域。中国、东南亚和中东等新兴市场正在快速发展医疗基础设施，为生物可吸收支架的大规模应用创造了有利条件。

儘管生物可吸收支架展现出良好的临床前景，但仍面临许多挑战。这些挑战包括材料强度不足、需要精确控制降解时间，以及与传统金属支架相比，其血管再阻塞率较高等问题。冗长且资料密集的监管流程延长了产品上市时间，加重了研发负担，也考验着投资人的耐心。此外，部分地区有限的健保报销管道也削弱了医院的购买力，并影响了医生对该技术的接受度。

下游市场对安全性高、能最大限度减少长期併发症的介入器材的需求呈现明显的上升趋势。 「可吸收微创」治疗概念在35-55岁的年轻患者、糖尿病患者以及长期服药的患者中越来越受欢迎。三级医院和专科中心越来越多地将生物可吸收支架应用于週边血管、神经血管和儿科先天性心臟疾病手术。这种临床应用范围从冠状动脉领域扩展到其他领域，推动了其广泛应用，创造了多样化的应用场景，并为市场的持续扩张奠定了基础。

本报告旨在按地区/国家、类型和应用对全球生物可吸收支架市场进行全面分析，重点关注总销售量、收入、价格、市场份额和主要企业的排名。

本报告以2024年为基准年，按销量（千件）和收入（百万美元）对生物可吸收支架市场规模、估计值和预测进行了呈现，并涵盖了2020年至2031年的历史数据和预测数据。报告采用定量和定性分析相结合的方法，帮助读者制定生物可吸收支架的业务/成长策略，评估市场竞争，分析自身在当前市场中的地位，并做出明智的商业决策。

市场区隔

公司

  • Abbott
  • Boston Scientific
  • Wego Healthcare
  • Elixir
  • Arterial Remodeling Technologies
  • Lepu Medical
  • Huaan Bio
  • ELLA-CS

按类型分類的细分市场

  • 外周生物可吸收支架
  • 生物可吸收冠状动脉支架

应用领域

  • 医院和诊所
  • 心臟导管实验室
  • 其他的

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Bioabsorbable Stents was estimated to be worth US$ 753 million in 2024 and is forecast to a readjusted size of US$ 1759 million by 2031 with a CAGR of 13.2% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Bioabsorbable Stents cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Bioabsorbable Stents are a class of high-end implantable medical devices used to treat cardiovascular or peripheral arterial stenosis. These stents are engineered to provide mechanical support during the critical healing phase and then gradually degrade and disappear within the body. Typically made from biodegradable materials such as poly-L-lactic acid (PLLA), magnesium alloys, or zinc alloys, they eliminate complications associated with permanent metallic implants-such as late thrombosis, restenosis, or interference with future imaging or interventions. As a transformative innovation in interventional therapy, bioabsorbable stents embody the shift from "permanent scaffolding" to "temporary healing support," offering particular clinical value for younger patients and those requiring sequential interventions, and are now driving the next wave of device evolution in structural heart and vascular therapy. In 2024, global Bioabsorbable Stents production reached approximately 376 k units, with an average global market price of around US$ 2000 per unit.

With the global rise in cardiovascular disease prevalence, minimally invasive interventional therapies are becoming the clinical standard. Bioabsorbable stents, as a next-generation high-performance implantable device, are drawing increasing attention from both healthcare systems and regulatory bodies. Several countries have included such products in fast-track approval channels and innovation pilot programs, accelerating commercialization. Leading medtech firms are also intensifying their investment in structural heart disease pipelines, significantly expanding the clinical application landscape of bioabsorbable stents to include peripheral, neurovascular, and pediatric indications. Emerging markets like China, Southeast Asia, and the Middle East are witnessing rapid healthcare infrastructure upgrades, creating fertile ground for large-scale adoption.

Despite their compelling clinical promise, bioabsorbable stents still face several challenges. These include suboptimal material strength, the need for precise degradation timing, and lingering concerns about restenosis rates compared to traditional metallic stents. Long and data-intensive regulatory processes prolong the time to market, increasing the burden on R&D and investor patience. Additionally, limited insurance reimbursement pathways in some regions are dampening purchasing momentum at hospitals and affecting physicians' willingness to adopt.

There is a clear upward trend in downstream demand for interventional devices with superior safety profiles and minimal long-term complications. Among younger patients aged 35-55, diabetics, and those on chronic medication, the concept of "absorbable, low-intervention" treatment is gaining traction. Tertiary hospitals and specialized centers are increasingly exploring the use of bioabsorbable stents in peripheral, neurovascular, and pediatric congenital heart disease procedures. This clinical spillover from the coronary sector is catalyzing broader adoption, shaping a more diversified use-case landscape and setting the stage for sustained market expansion.

This report aims to provide a comprehensive presentation of the global market for Bioabsorbable Stents, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Bioabsorbable Stents by region & country, by Type, and by Application.

The Bioabsorbable Stents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bioabsorbable Stents.

Market Segmentation

By Company

  • Abbott
  • Boston Scientific
  • Wego Healthcare
  • Elixir
  • Arterial Remodeling Technologies
  • Lepu Medical
  • Huaan Bio
  • ELLA-CS

Segment by Type

  • Peripheral Bioabsorbable Stents
  • Coronary Bioabsorbable Stents

Segment by Application

  • Hospitals and Clinics
  • Cardiac Catheterization Laboratory
  • Other

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Bioabsorbable Stents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Bioabsorbable Stents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Bioabsorbable Stents in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Bioabsorbable Stents Product Introduction
  • 1.2 Global Bioabsorbable Stents Market Size Forecast
    • 1.2.1 Global Bioabsorbable Stents Sales Value (2020-2031)
    • 1.2.2 Global Bioabsorbable Stents Sales Volume (2020-2031)
    • 1.2.3 Global Bioabsorbable Stents Sales Price (2020-2031)
  • 1.3 Bioabsorbable Stents Market Trends & Drivers
    • 1.3.1 Bioabsorbable Stents Industry Trends
    • 1.3.2 Bioabsorbable Stents Market Drivers & Opportunity
    • 1.3.3 Bioabsorbable Stents Market Challenges
    • 1.3.4 Bioabsorbable Stents Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Bioabsorbable Stents Players Revenue Ranking (2024)
  • 2.2 Global Bioabsorbable Stents Revenue by Company (2020-2025)
  • 2.3 Global Bioabsorbable Stents Players Sales Volume Ranking (2024)
  • 2.4 Global Bioabsorbable Stents Sales Volume by Company Players (2020-2025)
  • 2.5 Global Bioabsorbable Stents Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Bioabsorbable Stents Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Bioabsorbable Stents Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Bioabsorbable Stents
  • 2.9 Bioabsorbable Stents Market Competitive Analysis
    • 2.9.1 Bioabsorbable Stents Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Bioabsorbable Stents Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bioabsorbable Stents as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Peripheral Bioabsorbable Stents
    • 3.1.2 Coronary Bioabsorbable Stents
  • 3.2 Global Bioabsorbable Stents Sales Value by Type
    • 3.2.1 Global Bioabsorbable Stents Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Bioabsorbable Stents Sales Value, by Type (2020-2031)
    • 3.2.3 Global Bioabsorbable Stents Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Bioabsorbable Stents Sales Volume by Type
    • 3.3.1 Global Bioabsorbable Stents Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Bioabsorbable Stents Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Bioabsorbable Stents Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Bioabsorbable Stents Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Hospitals and Clinics
    • 4.1.2 Cardiac Catheterization Laboratory
    • 4.1.3 Other
  • 4.2 Global Bioabsorbable Stents Sales Value by Application
    • 4.2.1 Global Bioabsorbable Stents Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Bioabsorbable Stents Sales Value, by Application (2020-2031)
    • 4.2.3 Global Bioabsorbable Stents Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Bioabsorbable Stents Sales Volume by Application
    • 4.3.1 Global Bioabsorbable Stents Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Bioabsorbable Stents Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Bioabsorbable Stents Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Bioabsorbable Stents Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Bioabsorbable Stents Sales Value by Region
    • 5.1.1 Global Bioabsorbable Stents Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Bioabsorbable Stents Sales Value by Region (2020-2025)
    • 5.1.3 Global Bioabsorbable Stents Sales Value by Region (2026-2031)
    • 5.1.4 Global Bioabsorbable Stents Sales Value by Region (%), (2020-2031)
  • 5.2 Global Bioabsorbable Stents Sales Volume by Region
    • 5.2.1 Global Bioabsorbable Stents Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Bioabsorbable Stents Sales Volume by Region (2020-2025)
    • 5.2.3 Global Bioabsorbable Stents Sales Volume by Region (2026-2031)
    • 5.2.4 Global Bioabsorbable Stents Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Bioabsorbable Stents Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Bioabsorbable Stents Sales Value, 2020-2031
    • 5.4.2 North America Bioabsorbable Stents Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Bioabsorbable Stents Sales Value, 2020-2031
    • 5.5.2 Europe Bioabsorbable Stents Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Bioabsorbable Stents Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Bioabsorbable Stents Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Bioabsorbable Stents Sales Value, 2020-2031
    • 5.7.2 South America Bioabsorbable Stents Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Bioabsorbable Stents Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Bioabsorbable Stents Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Bioabsorbable Stents Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Bioabsorbable Stents Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Bioabsorbable Stents Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Bioabsorbable Stents Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Bioabsorbable Stents Sales Value, 2020-2031
    • 6.3.2 United States Bioabsorbable Stents Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Bioabsorbable Stents Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Bioabsorbable Stents Sales Value, 2020-2031
    • 6.4.2 Europe Bioabsorbable Stents Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Bioabsorbable Stents Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Bioabsorbable Stents Sales Value, 2020-2031
    • 6.5.2 China Bioabsorbable Stents Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Bioabsorbable Stents Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Bioabsorbable Stents Sales Value, 2020-2031
    • 6.6.2 Japan Bioabsorbable Stents Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Bioabsorbable Stents Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Bioabsorbable Stents Sales Value, 2020-2031
    • 6.7.2 South Korea Bioabsorbable Stents Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Bioabsorbable Stents Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Bioabsorbable Stents Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Bioabsorbable Stents Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Bioabsorbable Stents Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Bioabsorbable Stents Sales Value, 2020-2031
    • 6.9.2 India Bioabsorbable Stents Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Bioabsorbable Stents Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Abbott
    • 7.1.1 Abbott Company Information
    • 7.1.2 Abbott Introduction and Business Overview
    • 7.1.3 Abbott Bioabsorbable Stents Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Abbott Bioabsorbable Stents Product Offerings
    • 7.1.5 Abbott Recent Development
  • 7.2 Boston Scientific
    • 7.2.1 Boston Scientific Company Information
    • 7.2.2 Boston Scientific Introduction and Business Overview
    • 7.2.3 Boston Scientific Bioabsorbable Stents Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Boston Scientific Bioabsorbable Stents Product Offerings
    • 7.2.5 Boston Scientific Recent Development
  • 7.3 Wego Healthcare
    • 7.3.1 Wego Healthcare Company Information
    • 7.3.2 Wego Healthcare Introduction and Business Overview
    • 7.3.3 Wego Healthcare Bioabsorbable Stents Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Wego Healthcare Bioabsorbable Stents Product Offerings
    • 7.3.5 Wego Healthcare Recent Development
  • 7.4 Elixir
    • 7.4.1 Elixir Company Information
    • 7.4.2 Elixir Introduction and Business Overview
    • 7.4.3 Elixir Bioabsorbable Stents Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Elixir Bioabsorbable Stents Product Offerings
    • 7.4.5 Elixir Recent Development
  • 7.5 Arterial Remodeling Technologies
    • 7.5.1 Arterial Remodeling Technologies Company Information
    • 7.5.2 Arterial Remodeling Technologies Introduction and Business Overview
    • 7.5.3 Arterial Remodeling Technologies Bioabsorbable Stents Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Arterial Remodeling Technologies Bioabsorbable Stents Product Offerings
    • 7.5.5 Arterial Remodeling Technologies Recent Development
  • 7.6 Lepu Medical
    • 7.6.1 Lepu Medical Company Information
    • 7.6.2 Lepu Medical Introduction and Business Overview
    • 7.6.3 Lepu Medical Bioabsorbable Stents Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Lepu Medical Bioabsorbable Stents Product Offerings
    • 7.6.5 Lepu Medical Recent Development
  • 7.7 Huaan Bio
    • 7.7.1 Huaan Bio Company Information
    • 7.7.2 Huaan Bio Introduction and Business Overview
    • 7.7.3 Huaan Bio Bioabsorbable Stents Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Huaan Bio Bioabsorbable Stents Product Offerings
    • 7.7.5 Huaan Bio Recent Development
  • 7.8 ELLA-CS
    • 7.8.1 ELLA-CS Company Information
    • 7.8.2 ELLA-CS Introduction and Business Overview
    • 7.8.3 ELLA-CS Bioabsorbable Stents Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 ELLA-CS Bioabsorbable Stents Product Offerings
    • 7.8.5 ELLA-CS Recent Development

8 Industry Chain Analysis

  • 8.1 Bioabsorbable Stents Industrial Chain
  • 8.2 Bioabsorbable Stents Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Bioabsorbable Stents Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Bioabsorbable Stents Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Bioabsorbable Stents Market Trends
  • Table 2. Bioabsorbable Stents Market Drivers & Opportunity
  • Table 3. Bioabsorbable Stents Market Challenges
  • Table 4. Bioabsorbable Stents Market Restraints
  • Table 5. Global Bioabsorbable Stents Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Bioabsorbable Stents Revenue Market Share by Company (2020-2025)
  • Table 7. Global Bioabsorbable Stents Sales Volume by Company (2020-2025) & (K Units)
  • Table 8. Global Bioabsorbable Stents Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Bioabsorbable Stents Price by Company (2020-2025) & (US$/Unit)
  • Table 10. Key Manufacturers Bioabsorbable Stents Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Bioabsorbable Stents Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Bioabsorbable Stents
  • Table 13. Global Bioabsorbable Stents Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bioabsorbable Stents as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Bioabsorbable Stents Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Bioabsorbable Stents Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Bioabsorbable Stents Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Bioabsorbable Stents Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Bioabsorbable Stents Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Bioabsorbable Stents Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
  • Table 22. Global Bioabsorbable Stents Sales Volume by Type (2020-2025) & (K Units)
  • Table 23. Global Bioabsorbable Stents Sales Volume by Type (2026-2031) & (K Units)
  • Table 24. Global Bioabsorbable Stents Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Bioabsorbable Stents Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Bioabsorbable Stents Price by Type (2020-2025) & (US$/Unit)
  • Table 27. Global Bioabsorbable Stents Price by Type (2026-2031) & (US$/Unit)
  • Table 28. Global Bioabsorbable Stents Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Bioabsorbable Stents Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Bioabsorbable Stents Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Bioabsorbable Stents Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Bioabsorbable Stents Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Bioabsorbable Stents Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
  • Table 34. Global Bioabsorbable Stents Sales Volume by Application (2020-2025) & (K Units)
  • Table 35. Global Bioabsorbable Stents Sales Volume by Application (2026-2031) & (K Units)
  • Table 36. Global Bioabsorbable Stents Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Bioabsorbable Stents Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Bioabsorbable Stents Price by Application (2020-2025) & (US$/Unit)
  • Table 39. Global Bioabsorbable Stents Price by Application (2026-2031) & (US$/Unit)
  • Table 40. Global Bioabsorbable Stents Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Bioabsorbable Stents Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Bioabsorbable Stents Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Bioabsorbable Stents Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Bioabsorbable Stents Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Bioabsorbable Stents Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
  • Table 46. Global Bioabsorbable Stents Sales Volume by Region (2020-2025) & (K Units)
  • Table 47. Global Bioabsorbable Stents Sales Volume by Region (2026-2031) & (K Units)
  • Table 48. Global Bioabsorbable Stents Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Bioabsorbable Stents Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Bioabsorbable Stents Average Price by Region (2020-2025) & (US$/Unit)
  • Table 51. Global Bioabsorbable Stents Average Price by Region (2026-2031) & (US$/Unit)
  • Table 52. Key Countries/Regions Bioabsorbable Stents Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Bioabsorbable Stents Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Bioabsorbable Stents Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Bioabsorbable Stents Sales Volume, (2020-2025) & (K Units)
  • Table 56. Key Countries/Regions Bioabsorbable Stents Sales Volume, (2026-2031) & (K Units)
  • Table 57. Abbott Company Information
  • Table 58. Abbott Introduction and Business Overview
  • Table 59. Abbott Bioabsorbable Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 60. Abbott Bioabsorbable Stents Product Offerings
  • Table 61. Abbott Recent Development
  • Table 62. Boston Scientific Company Information
  • Table 63. Boston Scientific Introduction and Business Overview
  • Table 64. Boston Scientific Bioabsorbable Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 65. Boston Scientific Bioabsorbable Stents Product Offerings
  • Table 66. Boston Scientific Recent Development
  • Table 67. Wego Healthcare Company Information
  • Table 68. Wego Healthcare Introduction and Business Overview
  • Table 69. Wego Healthcare Bioabsorbable Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 70. Wego Healthcare Bioabsorbable Stents Product Offerings
  • Table 71. Wego Healthcare Recent Development
  • Table 72. Elixir Company Information
  • Table 73. Elixir Introduction and Business Overview
  • Table 74. Elixir Bioabsorbable Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 75. Elixir Bioabsorbable Stents Product Offerings
  • Table 76. Elixir Recent Development
  • Table 77. Arterial Remodeling Technologies Company Information
  • Table 78. Arterial Remodeling Technologies Introduction and Business Overview
  • Table 79. Arterial Remodeling Technologies Bioabsorbable Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 80. Arterial Remodeling Technologies Bioabsorbable Stents Product Offerings
  • Table 81. Arterial Remodeling Technologies Recent Development
  • Table 82. Lepu Medical Company Information
  • Table 83. Lepu Medical Introduction and Business Overview
  • Table 84. Lepu Medical Bioabsorbable Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 85. Lepu Medical Bioabsorbable Stents Product Offerings
  • Table 86. Lepu Medical Recent Development
  • Table 87. Huaan Bio Company Information
  • Table 88. Huaan Bio Introduction and Business Overview
  • Table 89. Huaan Bio Bioabsorbable Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 90. Huaan Bio Bioabsorbable Stents Product Offerings
  • Table 91. Huaan Bio Recent Development
  • Table 92. ELLA-CS Company Information
  • Table 93. ELLA-CS Introduction and Business Overview
  • Table 94. ELLA-CS Bioabsorbable Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 95. ELLA-CS Bioabsorbable Stents Product Offerings
  • Table 96. ELLA-CS Recent Development
  • Table 97. Key Raw Materials Lists
  • Table 98. Raw Materials Key Suppliers Lists
  • Table 99. Bioabsorbable Stents Downstream Customers
  • Table 100. Bioabsorbable Stents Distributors List
  • Table 101. Research Programs/Design for This Report
  • Table 102. Key Data Information from Secondary Sources
  • Table 103. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Bioabsorbable Stents Product Picture
  • Figure 2. Global Bioabsorbable Stents Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Bioabsorbable Stents Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Bioabsorbable Stents Sales Volume (2020-2031) & (K Units)
  • Figure 5. Global Bioabsorbable Stents Sales Price (2020-2031) & (US$/Unit)
  • Figure 6. Bioabsorbable Stents Report Years Considered
  • Figure 7. Global Bioabsorbable Stents Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Bioabsorbable Stents Players Sales Volume Ranking (2024) & (K Units)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Bioabsorbable Stents Revenue in 2024
  • Figure 10. Bioabsorbable Stents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Peripheral Bioabsorbable Stents Picture
  • Figure 12. Coronary Bioabsorbable Stents Picture
  • Figure 13. Global Bioabsorbable Stents Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 14. Global Bioabsorbable Stents Sales Value Market Share by Type, 2024 & 2031
  • Figure 15. Global Bioabsorbable Stents Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
  • Figure 16. Global Bioabsorbable Stents Sales Volume Market Share by Type, 2024 & 2031
  • Figure 17. Global Bioabsorbable Stents Price by Type (2020-2031) & (US$/Unit)
  • Figure 18. Product Picture of Hospitals and Clinics
  • Figure 19. Product Picture of Cardiac Catheterization Laboratory
  • Figure 20. Product Picture of Other
  • Figure 21. Global Bioabsorbable Stents Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 22. Global Bioabsorbable Stents Sales Value Market Share by Application, 2024 & 2031
  • Figure 23. Global Bioabsorbable Stents Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
  • Figure 24. Global Bioabsorbable Stents Sales Volume Market Share by Application, 2024 & 2031
  • Figure 25. Global Bioabsorbable Stents Price by Application (2020-2031) & (US$/Unit)
  • Figure 26. North America Bioabsorbable Stents Sales Value (2020-2031) & (US$ Million)
  • Figure 27. North America Bioabsorbable Stents Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Europe Bioabsorbable Stents Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Europe Bioabsorbable Stents Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Asia Pacific Bioabsorbable Stents Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Asia Pacific Bioabsorbable Stents Sales Value by Region (%), 2024 VS 2031
  • Figure 32. South America Bioabsorbable Stents Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. South America Bioabsorbable Stents Sales Value by Country (%), 2024 VS 2031
  • Figure 34. Middle East & Africa Bioabsorbable Stents Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Middle East & Africa Bioabsorbable Stents Sales Value by Country (%), 2024 VS 2031
  • Figure 36. Key Countries/Regions Bioabsorbable Stents Sales Value (%), (2020-2031)
  • Figure 37. Key Countries/Regions Bioabsorbable Stents Sales Volume (%), (2020-2031)
  • Figure 38. United States Bioabsorbable Stents Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. United States Bioabsorbable Stents Sales Value by Type (%), 2024 VS 2031
  • Figure 40. United States Bioabsorbable Stents Sales Value by Application (%), 2024 VS 2031
  • Figure 41. Europe Bioabsorbable Stents Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. Europe Bioabsorbable Stents Sales Value by Type (%), 2024 VS 2031
  • Figure 43. Europe Bioabsorbable Stents Sales Value by Application (%), 2024 VS 2031
  • Figure 44. China Bioabsorbable Stents Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. China Bioabsorbable Stents Sales Value by Type (%), 2024 VS 2031
  • Figure 46. China Bioabsorbable Stents Sales Value by Application (%), 2024 VS 2031
  • Figure 47. Japan Bioabsorbable Stents Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. Japan Bioabsorbable Stents Sales Value by Type (%), 2024 VS 2031
  • Figure 49. Japan Bioabsorbable Stents Sales Value by Application (%), 2024 VS 2031
  • Figure 50. South Korea Bioabsorbable Stents Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. South Korea Bioabsorbable Stents Sales Value by Type (%), 2024 VS 2031
  • Figure 52. South Korea Bioabsorbable Stents Sales Value by Application (%), 2024 VS 2031
  • Figure 53. Southeast Asia Bioabsorbable Stents Sales Value, (2020-2031) & (US$ Million)
  • Figure 54. Southeast Asia Bioabsorbable Stents Sales Value by Type (%), 2024 VS 2031
  • Figure 55. Southeast Asia Bioabsorbable Stents Sales Value by Application (%), 2024 VS 2031
  • Figure 56. India Bioabsorbable Stents Sales Value, (2020-2031) & (US$ Million)
  • Figure 57. India Bioabsorbable Stents Sales Value by Type (%), 2024 VS 2031
  • Figure 58. India Bioabsorbable Stents Sales Value by Application (%), 2024 VS 2031
  • Figure 59. Bioabsorbable Stents Industrial Chain
  • Figure 60. Bioabsorbable Stents Manufacturing Cost Structure
  • Figure 61. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 62. Bottom-up and Top-down Approaches for This Report
  • Figure 63. Data Triangulation
  • Figure 64. Key Executives Interviewed